PhableCare, India’s largest chronic disease management company, said Monday it has raised Series B funding of INR187 crores ($25 million) led by Kalaari Capital with participation from Aflac Ventures, Digital Horizon, Stride Ventures.

Existing investors, Omron Ventures, SOSV, Social Starts, and Fresco Capital also participated in the round, PhableCare said in a statement.

This funding round comes within a year of its Series A round, marking a six times jump in PhableCare’s valuation within a short time.

The company will use this investment to further strengthen its full-stack and value-driven chronic care ecosystem and accelerate its market expansion, customer acquisition (doctors and patients), brand building, and building new revenue streams

The start-up has plans to acquire other players through strategic investments, which will consolidate PhableCare’s position in the category. The company has also allocated capital and secured additional venture debt to invest in other health-tech startups that can potentially create a thriving healthcare eco-system through capacity and capability expansion.

“We believe that India needs a focused chronic care management ecosystem as chronic care has the largest burden on the overall healthcare expenditure. At Phable, we constantly help Chronic Disease Patients to manage their ailment at lower cost and stay out of a hospital for as long as possible. We have demonstrated that this problem can be solved effectively at scale with digital solutions, connected care ecosystem, internet of thing (IOT) devices, and data,” said Sumit Sinha, Co-Founder, PhableCare.

PhableCare Co-Founder Mukesh Bansal added the group’s focus over the next next years would be to take the technology to 30 Million+ Indian households and 100,000+ super specialist doctors in India and capture 25 percent of the market.

“In addition, we will continue to build technology to integrate the healthcare system and players even further,” he said.

PhableCare is an app-based and specialized platform for chronic disease care. The innovative disease management app bridges the gap between doctors and patients through a full-stack solution that delivers remote consultations and care, timely and intelligent insights, and simplified access to healthcare essentials.

The firm has built an ecosystem of care providers, hospitals, medical device manufacturers, health and wellness product manufacturers, e-Pharmacy retailers, and insurance partners to bring digital healthcare to millions of Indians. Its complete solution for doctors is powered by a decision support system and simplifies patient engagement and clinic management. It helps doctors extend their practice beyond geographical boundaries and build better relationships with patients.

Currently three million+ patients and 10,000+ doctors and over 1000+ pharmacists use PhableCare’s technology making it the market leader in this segment. The new investment further bolsters PhableCare’s rapid growth in 2021

“We are delighted to partner with Sumit and Mukesh in their mission to revolutionize chronic disease management. Their experience and deep insights into the market, coupled with their entrepreneurial experience, reinforce our confidence in their ability to disrupt digital health in India,” said Vani Kola, Managing Director, Kalaari Capital.

Prior to the current Series B funding led by Kalaari Capital, Phablecare had secured INR 90 crores in Series-A funding led by Manipal Hospitals in March 2021. Later 2021, the start-up received an additional INR 14 cr from Omron Ventures through primary capital infusion and a venture debt facility committed of INR 45 cr from Stride Ventures.

Indian healthtech startup Qure raises $40M from Novo Holdings and HealthQuad